Highest-materiality recent filing
Nordicus appoints three new directors after Keller resignation
Henrik Keller resigned from Board effective August 7, 2025 to pursue other interests.
Nordicus Partners acquires 100% of Bio-Convert ApS for 12M restricted shares
Acquired 100% of Danish clinical-stage biopharma Bio-Convert ApS on Nov 12, 2024.
Nordicus acquires 95% of Orocidin A/S for $38M in stock, enters periodontitis market
Acquired 525,597 Orocidin shares (95% stake) from 11 shareholders for 38M restricted common shares.
EKIMAS acquires Nordicus Partners in stock-for-stock deal, exits shell company status
Acquired 100% of Nordicus Partners A/S for 2,500,000 shares of EKIMAS common stock.
EKIMAS completes stock sale to Reddington; 90% ownership after reverse split
Reddington acquired 51.8% at first close on Oct. 12, 2021, then 90% after second tranche and 1-for-50 reverse split on Mar. 11, 2022.
Reddington Partners acquires 51.8% of EKIMAS; CEO Adams resigns, Yankowitz appointed
Reddington Partners acquired 51.8% ownership (25.57M shares) on Oct 12, 2021, becoming majority stockholder.
On July 7, 2026, Andrew J. Ritter resigned from the Board of Directors of Nordicus Partners Corporation (the “Company”), effective immediately, to pursue other time-consuming business opportunities.
and the remaining Board members appointed Peter Severin as his replacement and as Chairman of the Board of Directors.
Effective June 3, 2024, Christian Hill-Madsen resigned from the Board of Directors of Nordicus Partners Corporation (the “Company”), and the remaining Board members appointed Peter Severin as his replacement and as Chairman of the Board of Directors.
On June 9, 2023, Tom Glasesner Larsen resigned from the Company’s board of directors, and the remaining board members appointed Henrik Keller as his replacement.
On June 9, 2023, Tom Glasesner Larsen resigned from the Company’s board of directors, and the remaining board members appointed Henrik Keller as his replacement.
Bennett J. Yankowitz was appointed as the Company's chief executive officer and sole director.
Michael F. Adams resigned as the chief executive officer and sole director of the Company
Max materiality 0.90 · Median 0.35 · Most common event other_material